Improving asthma care for people with frequent flare-ups
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study aims to improve care for people with asthma who are at higher risk of severe flare-ups. It may test new ways to manage asthma and help you avoid hospital visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have had asthma for at least 1 year.
- You have had a severe asthma flare-up in the last 12 months that required steroids for 3 or more days or a hospital stay.
- You are currently using a daily combination inhaler that contains an inhaled steroid (ICS) and a long-acting bronchodilator (LABA) — for example, Advair, Symbicort, or Breo.
- You have a rescue inhaler (like albuterol) that you use at least once a month on average.
- You do not have COPD or other major lung diseases, and you have not had a flare-up in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes how asthma is managed and controlled in routine clinical practice. Researchers will collect information about your asthma symptoms, treatments, and outcomes over time to better understand real-world asthma management.
This study tests whether switching to a higher-dose or extrafine triple inhaler helps people whose asthma is still uncontrolled on their current medium-dose combination inhaler. It focuses on improving small-airway function, which may lead to better symptom control.
This study tests a program that combines exercise and other support to help people with difficult-to-control asthma feel better and be more active. It aims to improve your symptoms and quality of life.
This study looks at whether a new approach can help more people get connected with asthma specialists after an emergency room visit. If you have asthma and recently went to the ER, this trial may help you get expert follow-up care to better manage your condition.
This study follows people with moderate-to-severe asthma and repeatedly checks how their lungs and symptoms relate to environmental exposures over time. It may help researchers better understand what triggers asthma and how exposures affect asthma control.
This study tests whether adding a long-term, low-dose antibiotic (azithromycin) to your usual asthma treatment can help improve control and reduce attacks. It is for people whose asthma is still not well controlled despite using a daily inhaler.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.